Elizabeth Hurlburt sold $1.6M of CRMD
EVP at CorMedix Inc.. 140,027 shares at an average of $11.18, traded Nov 14, 2024, filed Nov 18, 2024.
Score components
- +15RoleOfficer
- +25Trade size$1.6M at market
- +20Share of holdings soldSold 76% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -25.6%, 3m -3.9%, 6m +16.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000899140-24-001286, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 14, 2024 | MOption exercise Common Stock | +3 | $1.45 | $4 | 45,400 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Common Stock | +8,169 | $8.30 | $68k | 53,569 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Common Stock | +9,888 | $5.63 | $56k | 63,457 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Common Stock | +34,467 | $4.08 | $141k | 97,924 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Common Stock | +62,500 | $4.43 | $277k | 160,424 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Common Stock | +25,000 | $3.47 | $87k | 185,424 | Nov 18, 2024 |
| Nov 14, 2024 | SOpen-market sale Common Stock | -140,027 | $11.18 | $1.6M | 45,397 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -3 | $0.00 | $0 | 53,997 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -8,169 | $0.00 | $0 | 12,711 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -9,888 | $0.00 | $0 | 27,612 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -34,467 | $0.00 | $0 | 3,033 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -62,500 | $0.00 | $0 | 62,500 | Nov 18, 2024 |
| Nov 14, 2024 | MOption exercise Stock Option (Right to Buy Common Stock)derivative | -25,000 | $0.00 | $0 | 75,000 | Nov 18, 2024 |
Related signals
Other insiders at CorMedix Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | CorMedix Inc. | Janet Dillione director | $69k 10,000 shares | -21% | |
| 11Weak | CorMedix Inc. | Alan W Dunton director | $260k 20,000 shares | -33% | |
| 20Weak | CorMedix Inc. | Joseph Todisco Chief Executive Officer | $360k 30,000 shares | -6% | |
| 21Weak | CorMedix Inc. | Janet Dillione director | $408k 34,000 shares | -41% | |
| 58Moderate | CorMedix Inc. | Steven W Lefkowitz director | $475k 40,000 shares | -33% | |
| 15Weak | CorMedix Inc. | Janet Dillione director | $467k 46,657 shares | -49% | |
| 23Weak | CRMDsell CorMedix Inc. | Janet Dillione director | $262k 26,343 shares | -35% | |
| 40Moderate | CRMDsell CorMedix Inc. | Janet Dillione director | $343k 30,000 shares | -38% | |
| 40Moderate | CRMDbuy CorMedix Inc. | Myron Kaplan director | $276k 25,000 shares | +14% | |
| 31Weak | CorMedix Inc. | Alan W Dunton director | $131k 10,000 shares | -20% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.